Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-14
DOI
10.1038/srep36855
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats
- (2016) Basel A. Abdel-Wahab et al. BEHAVIOURAL BRAIN RESEARCH
- Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation
- (2016) Ming Wu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages
- (2015) Thabe M. Matsebatlela et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6
- (2015) Hua Sun et al. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
- The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
- (2015) Ghada A. Abdel-Latif et al. Scientific Reports
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
- (2014) Zhen Liu et al. PLoS One
- The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML
- (2014) Guerry J. Cook et al. PLoS One
- Resveratrol As Anti-Aging Therapy for Age-Related Bone Loss
- (2014) Isabel F. Tresguerres et al. REJUVENATION RESEARCH
- Cytotoxic activity of acyl phloroglucinols isolated from the leaves of Eucalyptus cinerea F. Muell. ex Benth. cultivated in Egypt
- (2014) Fathy M. Soliman et al. Scientific Reports
- Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
- (2013) J. Prados et al. Anti-Cancer Agents in Medicinal Chemistry
- Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase
- (2013) Lilian S. Gomez et al. BIOCHIMIE
- Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression
- (2013) P. Liu et al. Clinical & Translational Oncology
- Selective cytotoxic effects on human breast carcinoma of new methoxylated flavonoids from Euryops arabicus grown in Saudi Arabia
- (2013) Walied M. Alarif et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity
- (2013) Ahmed M. Al-Abd et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dual role of resveratrol in modulation of genotoxicity induced by sodium arsenite via oxidative stress and apoptosis
- (2013) Chengzhi Chen et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways
- (2013) MEIHONG ZHANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells
- (2013) ZHIYU ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells
- (2013) Mai F. Tolba et al. IUBMB LIFE
- Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft
- (2013) Anil Mittal et al. PHYTOMEDICINE
- Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)
- (2012) Fabrizia Brisdelli et al. CURRENT DRUG METABOLISM
- Cytotoxic ellagitannins from Reaumuria vermiculata
- (2012) Mahmoud A. Nawwar et al. FITOTERAPIA
- Chemopreventive effects of resveratrol and resveratrol derivatives
- (2011) Thomas Szekeres et al. Annals of the New York Academy of Sciences
- Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro
- (2011) A. M. Al-Abd et al. CELL PROLIFERATION
- Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
- (2011) Bettina M. Kaminski et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent
- (2011) Ali Mokhtar Mahmoud et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin
- (2010) Katharina Effenberger-Neidnicht et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase
- (2010) N. Oi et al. CANCER RESEARCH
- Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection
- (2009) Ru Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Epigenetic mechanisms involved in differential MDR1mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy
- (2008) Tae-Bum Lee et al. BMC GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started